Safety and Medico-Legal Implications of Intra-articular Gadolinium Use

Seminars in Ultrasound CT and MRI

Volumn 18, Issue 4, 1997, Pages 276-277

  Balkissoon, A R A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; GADOLINIUM PENTETATE;

CONTRAST ENHANCEMENT; DRUG APPROVAL; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HUMAN; MEDICOLEGAL ASPECT; NOTE; PRESCRIPTION; PRIORITY JOURNAL; RADIOLOGIST;

EID: 0030751822     PISSN: 08872171     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0887-2171(97)80018-2     Document Type: Note

References (10)

1. Niendorf HP Haustein J Corneilius I Safety of gadolinium-DTPA: Extended clinical experience Magn Reson Med 22 1991 222 228
2. Goldstein HA Kashanian FK Blumetti RF Safety assessment of gadopentetate dimeglumine in U.S. clinical trials Radiology 174 1990 17 23
3. Nelson KL Gifford LM Lauber-Huber C Clinical safety of gadopentetate dimeglumine Radiology 196 1995 439 443
4. Ge HL Hirsch WL Wolf GL Diagnostic role of gadolinium-DPTA in pediatric neuroradiology: A retrospective review of 655 cases Neuroradiology 34 1992 122 125
5. Kashanian FK Goldstein HA Blumetti RF Rapid bolus injection of gadopentetate dimeglumine: Absence of side effects in normal volunteers AJNR 11 1990 853 856
6. Salonen OLM Case of anaphylaxis and four cases of allergic reactions following Gd-DTPA administration J Comput Assist Tomogr 14 1990 912 913
7. Hajek PC Sartoris DJ Gylys-Morin V The effect of intra-articular gadolinium-DTPA on synovial membrane and cartilage Invest Radiol 25 1990 179 183
8. Use of Approved Drugs for Unlabeled Indications FDA Drug Bulletin 12 1982 1 April
9. April Investigational Use of Marketed Products Department of Health Human Services Food and Drug Administration Bulletin 1984
10. Reuter SR Letter AJR 163 1994 749